Paper
0
CT-439 Clinical Experience of Tabelecleucel in Epstein–Barr Virus-Positive Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Involving the Central Nervous System
Authors
Published
Sep 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.